Ideal for fast O2 transition studies, the VelO2x system is designed to provide a controlled and isolated environment where rapid changes in O2 is required, ideal for use within animal research models. VelO2x allows the researcher to better understand the impact that rapidly changing oxygen levels has in conditions such as sleep apnea, hypertension, pulmonary dysfunction and ischemia and others.
The VelO2x system features Baker Ruskinn’s proprietary gas mixing technology, the ICONIC Gas Mixer, to provide pinpoint control of O2 directly to the chamber. Other key features of the VelO2x include:
Relevant Research Applications include but are not limited to:
In addition to the VelO2x, Baker & Baker Ruskinn feature the following complimentary equipment solution:
To learn more about these solutions, please contact us at: bakerco@bakerco.com
The Baker Ruskinn Bugbox is economical with a lower cost per plate, more reliable and provides a stable environment. Download our Bugbox vs. Jars Cost Comparison poster and see an ‘easy to justify’ alternative to anaerobic jars. Find out if you could save money by switching to Bugbox!
Need references for your physiological or anaerobic study? Browse this extensive list of more than 900 articles using key words and other easy-to-search criteria. These articles represent more than 15 years of research in hypoxia and anoxia, with many entries linking directly to abstracts for your further investigation.
The Baker Company has long been identified as an industry pioneer in the field of biological safety with an unparalleled passion for helping its customers advance science, discovery and clinical care. The company was first established back in 1949 in response to a growing need to protect hospital workers from infectious diseases and the dangerous process of drug preparation. As solutions for air containment and contamination control have evolved over the years, The Baker Company has been at the forefront of design and innovation, always believing that there are no shortcuts and that there should be no minimum standards applied to the solutions that they supply.
In 2011, the company acquired Ruskinn Technology Ltd., one of the world’s leading suppliers of gas-controlled, anaerobic, and modified atmosphere workstations for use in medical microbiology, cell biology, cancer research, molecular medicine and stem cell laboratories.
© 2020 Baker, All Rights Reserved